Cat Hyperthyroidism: Long-Term Welfare and Treatment Choices

Comparing treatment options for feline hyperthyroidism and how each affects the long-term welfare and quality of life of affected cats.

Key Facts

Hyperthyroidism is the most common endocrine disorder in cats, predominantly affecting those over 10 years of age
Benign thyroid adenoma accounts for over 98% of cases — malignant carcinoma is rare
Untreated hyperthyroidism causes weight loss, cardiac hypertrophy, hypertension and chronic anxiety despite a ravenous appetite
Four treatment options exist: daily methimazole, radioactive iodine (I-131), surgical thyroidectomy and iodine-restricted diet
Radioactive iodine achieves cure in over 95% of cases with a single treatment and is considered the gold standard
Masking hyperthyroidism can unmask concurrent chronic kidney disease — renal function must be assessed pre- and post-treatment

Welfare Considerations

Feline hyperthyroidism causes significant chronic welfare harm before diagnosis: the hypermetabolic state drives constant hunger, weight loss despite eating, restlessness, vomiting and cardiac strain. Many owners observe these signs for months before seeking veterinary attention, attributing them to normal ageing. Once treated, most cats show rapid improvement in weight, coat, behaviour and cardiac function. The welfare implications of each treatment differ: daily methimazole is burdensome for cats that resist pilling; radioactive iodine requires isolation of the cat for 2–3 weeks which can cause social deprivation; surgery carries anaesthetic risk in older animals. Individualised treatment selection matters for welfare outcomes.

What You Can Do

Have any cat over 8 years of age checked for hyperthyroidism annually — a simple blood T4 test suffices for screening
Discuss all four treatment options with your vet and consider your cat's temperament, concurrent health and your ability to medicate daily
Ask about radioactive iodine referral if you cannot reliably give daily medication — it offers permanent cure
Monitor blood pressure before and after treatment — hypertension requires separate management
Recheck kidney function 4 weeks after treatment begins — watch for emerging CKD
Provide extra caloric support during the early treatment phase as the hypermetabolic state resolves and appetite normalises